Financials in USD. Standardized financial statements.
A compact view of how SBC Medical Group Holdings Incorporated turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue? | $173.61M | $205.42M | $193.54M | $174.16M |
| Revenue Growth? | -15.5% | +6.1% | +11.1% | 0.0% |
| Cost of Revenue? | $46.32M | $49.37M | $56.24M | $59.33M |
| Gross Profit? | $127.28M | $156.05M | $137.30M | $114.83M |
| Gross Margin? | +73.3% | +76.0% | +70.9% | +65.9% |
| Operating Expenses? | $59.80M | $85.75M | $66.64M | $94.72M |
| Operating Income? | $67.49M | $70.30M | $70.66M | $20.12M |
| EBITDA? | $84.91M | $77.28M | $85.87M | $29.64M |
| Income Before Tax | $82.07M | $73.46M | $73.58M | $23.68M |
| Income Tax Expense | $31.02M | $26.77M | $35.02M | $18.12M |
| Net Income? | $50.99M | $46.61M | $39.37M | $6.32M |
| EPS? | $0.50 | $0.48 | $0.42 | $0.06 |
| Diluted EPS? | $0.50 | $0.48 | $0.42 | $0.06 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality